Skip to main content

Table 5 Human in-vitro cancer cell lines showing a complete response to 200 μM THR53

From: Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4

Cell Line

Source

Histology

MGHU-1

ICR Sutton, Surrey

Carcinoma Bladder

H460

ATCC HTB-177NCI

Non-Small Cell Lung Carcinoma

SW620

ATCC CCL-227

Adenocarcinoma Colon

G361

ECACC 88030461

Melanoma

MCF7

ECACC 86012803

Adenocarcinoma Breast

H1299

ATCC CRL-5803

Non-Small Cell Lung Carcinoma

SK-BR-3

ATCC HTB-30

Adenocarcinoma Breast

A375

ATCC CRL-1619

Melanoma

U2OS

ATCC HTB-96

Osteosarcoma

SW480

ECACC 87092801

Adenocarcinoma Colon

RT112

ECACC 85061106

Carcinoma Bladder